Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence and factors associated with potentially inappropriate medication and medication complexity for older adults in the emergency department of a secondary teaching hospital in Indonesia.
Hamidah KF, Rahmadi M, Meutia F, Kriswidyatomo P, Rahman FS, Izzah Z, Zulkarnain BS, Aminde LN, Alderman CP, Yulistiani, Suprapti B. Hamidah KF, et al. Pharm Pract (Granada). 2022 Oct-Dec;20(4):2735. doi: 10.18549/PharmPract.2022.4.2735. Epub 2022 Nov 8. Pharm Pract (Granada). 2022. PMID: 36793915 Free PMC article.
An in vitro study of dual drug combinations of anti-viral agents, antibiotics, and/or hydroxychloroquine against the SARS-CoV-2 virus isolated from hospitalized patients in Surabaya, Indonesia.
Purwati, Miatmoko A, Nasronudin, Hendrianto E, Karsari D, Dinaryanti A, Ertanti N, Ihsan IS, Purnama DS, Asmarawati TP, Marfiani E, Yulistiani, Rosyid AN, Wulaningrum PA, Setiawan HW, Siswanto I, Tri Puspaningsih NN. Purwati, et al. PLoS One. 2021 Jun 18;16(6):e0252302. doi: 10.1371/journal.pone.0252302. eCollection 2021. PLoS One. 2021. PMID: 34143818 Free PMC article.
A Randomized, Double-Blind, Multicenter Clinical Study Comparing the Efficacy and Safety of a Drug Combination of Lopinavir/Ritonavir-Azithromycin, Lopinavir/Ritonavir-Doxycycline, and Azithromycin-Hydroxychloroquine for Patients Diagnosed with Mild to Moderate COVID-19 Infections.
Purwati, Budiono, Rachman BE, Yulistiani, Miatmoko A, Nasronudin, Lardo S, Purnama YI, Laely M, Rochmad I, Ismail T, Wulandari S, Setyawan D, Rosyid AN, Setiawan HW, Wulaningrum PA, Asmarawati TP, Marfiani E, Yuniati SK, Fuadi MR, Endraswari PD, Purwaningsih, Hendrianto E, Karsari D, Dinaryanti A, Ertanti N, Ihsan IS, Purnama DS, Indrayani Y. Purwati, et al. Biochem Res Int. 2021 Feb 9;2021:6685921. doi: 10.1155/2021/6685921. eCollection 2021. Biochem Res Int. 2021. PMID: 33628506 Free PMC article.
11 results